Real-World Study of Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Arterial Hypertension (PAH)
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
Real-World Study of PADN for the Treatment of PAH
Eligibility
Participation Requirements
Sex: All
View:
• Diagnosed with PAH and received PADN procedure since March 2024.
• No contraindications to procedure.
• Able to provide informed consent and authorize use of health/research data.
• Compliant with treatment and follow-up requirements.
Locations
Other Locations
China
The First Affiliated Hospital with Nanjing Medical University
RECRUITING
Nanjing
Time Frame
Start Date: 2025-03-19
Estimated Completion Date: 2028-12-30
Participants
Target number of participants: 200
Related Therapeutic Areas
Sponsors
Leads: Pulnovo Medical (Wuxi) Co., Ltd.